Ammonium tetrafluoroborate
| Common Name: |
Ammonium tetrafluoroborate |
| IUPAC Name: |
azanium;tetrafluoroborate |
| Molecular Formula: |
BF4H4N |
| SMILES: |
[B-](F)(F)(F)F.[NH4+] |
| Inchi: |
1S/BF4.H3N/c2-1(3,4)5;/h;1H3/q-1;/p+1 |
| Inchi Key: |
PDTKOBRZPAIMRD-UHFFFAOYSA-O |
| Cas No: |
13826-83-0 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
0 |
| Name |
Value |
| Molecular Weight (g/mol) |
104.84 |
| Mass (g/mol) |
105.037 |
| Molar Refractivity |
16.17 |
| Net Charge |
|
| HBD |
1 |
| HBA |
5 |
| Rt Bonds |
0 |
| Rings |
|
| TPSA |
0.00 |
| Hetero Atoms |
|
| Heavy Atoms |
6 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
487 |
| Boiling Point (°C@760.00mm Hg) |
|
| Vapor Pressure (mmHg@25.00 °C) |
|
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.32 |
| LogP |
|
| iLOGP |
2.66 |
| XLOGP3 |
2.49 |
| WLOGP |
1.76 |
| MLOGP |
1.41 |
| ESOL Log S |
-4.00 |
| ESOL Solubility (mg/ml) |
0.044 |
| ESOL Solubility (mol/l) |
0 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-4.58 |
| Ali Solubility (mg/ml) |
0.01 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Moderately soluble |
| Silicos-IT LogSw |
-4.73 |
| Silicos-IT Solubility (mg/ml) |
0.01 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Moderately soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
0 |
| PgP Substrate |
1 |
| Log Kp (cm/s) |
-7.19 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
0 |
| Plasm Protein Binding |
0.485 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
1 |
| CYP2C9 Inhibitor |
1 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
1 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
3.083 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
